MIR193BHG

Across TCGA pan-cancer cohorts, MIR193BHG RNA is linked to patient survival in 29 of 34 cancer types, making it the most broadly survival-associated MIR193BHG data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MIR193BHG RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR193BHG expression acts as an unfavorable survival marker, although some lineages such as ESCA and LAML show a favorable association.

UVM, KIRC, and MESO are the cancer types where MIR193BHG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	III,IV	0.350	0.957	<.001	117	view →
KIRC	DFS	Tertile	II,III,IV	0.491	0.763	<.001	105	view →
MESO	OS	Quartile	All	0.310	0.600	<.001	103	view →
BLCA	OS	Tertile	All	0.339	0.512	.001	87	view →
UCEC	DFS	Median	IV	0.468	0.863	.002	58	view →
STAD	DFS	Tertile	All	0.471	0.631	.013	38	view →
HNSC	DFS	Quartile	All	0.607	0.752	.003	37	view →
CESC	OS	Median	All	0.814	0.929	.001	36	view →
PAAD	DFS	Quartile	All	0.171	0.433	.005	30	view →
THCA	DFS	Median	II,III,IV	0.875	0.936	.010	24	view →
PCPG	DFS	Tertile	All	0.797	0.982	.001	20	view →
OV	OS	Tertile	II,III,IV	0.267	0.375	.007	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 29 lineages.

MIR193BHG–UVM (OS)

Open the UVM breakdown →